The IMPACT Initiative
Familial hypercholesterolemia (FH) is a genetic disorder in which gene mutations prevent removal of excess cholesterol from the blood. Heterozygous FH (inherited from one parent) affects in excess of 1 million people in the US; while the homozygous form (inherited from both parents) is much more severe and rare, affecting around 1,300 US individuals.
Our IMPACT program is an online tool that aims to provide clinicians and patients with up-to-date information on the presentation, prognosis, pathophysiology, and treatment strategies for individuals with FH who are at high risk for CVD.
Clinician Scientific &
Patient & Caregiver
This activity is provided by Med Learning Group.
This activity is co-provided by Ultimate Medical Academy/Complete Conference Management.
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.